Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD —results from COSYCONET
MRproANP and COPAVP are prognostic markers for mortality in chronic obstructive pulmonary disease (COPD). Furthermore, these biomarkers predict mortality due to cardiovascular diseases, which are important pro...
Source: Respiratory Research - Category: Respiratory Medicine Authors: S. F ähndrich, C. Herr, S. Teuteberg, P. Alter, S. Söhler, D. Soriano, J. Classen, J. Adams, V. Weinhold, H. Watz, B. Waschki, T. Zeller, M. Eichenlaub, F. C. Trudzinski, J. D. Michels, A. Omlor & hellip; Tags: Research Source Type: research
More News: Cardiology | Cardiovascular | Chronic Obstructive Pulmonary | Heart | Respiratory Medicine